TransMedics Group, Inc. (TMDX)
67.20
-0.63
(-0.93%)
USD |
NASDAQ |
May 29, 16:00
67.29
+0.09
(+0.13%)
After-Hours: 20:00
TransMedics Group Cash from Investing (Quarterly) : -36.66M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -20.32B |
| DexCom, Inc. | -298.50M |
| Integer Holdings Corp. | -37.90M |
| Globus Medical, Inc. | -182.67M |
| GlucoTrack, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 24.53M |
| Cash from Financing (Quarterly) | 3.762M |
| Free Cash Flow | 151.36M |
| Free Cash Flow Per Share (Quarterly) | -0.335 |
| Free Cash Flow to Equity (Quarterly) | -356.26M |
| Free Cash Flow to Firm (Quarterly) | -5.943M |
| Free Cash Flow Yield | 5.69% |